STOK

STOKE THERAPEUTICS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

STOKE THERAPEUTICS INC (STOK) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$133.73M; the largest are Baker Bros. Advisors, Ken Griffin, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 1 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · LowThis quarter · Quiet

Common-stock holders31 also report options

Congress trades0

Price$25.88vs quarter-end-20.90%

Sectors0

This quarter's moves

New0

Added1

Trimmed / sold1

Top holderBaker Bros. Advisors

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Baker Bros. AdvisorsHold

Value $109.18M0.5% of portfolio3,336,6972026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Baker Bros. Advisors	2026 Q2	$109.18M	3,336,697	0.5%	Hold

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinPUT—

Value $327.2K— of portfolio10,0002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinPUT	2026 Q2	$327.2K	10,000	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.